This site is intended for Healthcare Professionals only

MHRA

advertising-standards-authority-1280

ASA bans ads promoting POM weight loss pills – including one on a bus

Two ads by Voy under its ‘The weight is over’ campaign were banned, one of which was seen in an image on a bus in July this year.

04 Nov 2026

coroners-court-1280

Warnings about ofloxacin risk provide ‘insufficient safeguards’, says coroner after suicide

An inquest heard Alexander Mulroney took his own life after taking the fluoroquinolone antibiotic.

02 Nov 2026

heart-attack-1280

Medicine prescribed after heart attack or stroke recalled by manufacturer

Xeal Pharma said all strengths of Clopidogrel Oral Suspension and Clopidogrel Oral Solution products contain less than the required amount of clopidogrel.

27 Oct 2026

1280

MHRA seizes £2 million worth of fake weight loss medicines in Birmingham

The raid, also conducted by West Midlands Police, seized over 12,000 fake retatrutide and tirzepatide pens and packaging for 30,000 more products.

15 Oct 2026

wegovy-tablet-pic-1280

First ads promoting prescription oral weight loss drugs banned

The Advertising Standards Authority said adverts from Simple Online Pharmacy and Pharmacy Online broke the rules.

07 Oct 2026

weight-loss-1280

Pharmacies that breached POM weight loss rules amend advertising

Infringements involved the distribution of emails, website homepages and posters on pharmacy premises.

06 Oct 2026

propranolol-1280

RCPharm urges MHRA to review safety information for propranolol

The Royal College of Pharmacy is concerned people at risk of overdose, self-harm and suicide continue to be prescribed the medicine.

17 Sep 2026

fake-online-pharmacy-1280

GPhC: Labour must oversee 'system-wide approach' to battle fake online pharmacies

The General Pharmaceutical Council said it can only “directly oversee legitimate providers”.

14 Sep 2026

tablets-1280

MHRA suspends use, supply and sale of Avacopan Vifor to new patients

The medicines regulator said the study underpinning the drug's authorisation can no longer be relied on to demonstrate its efficacy.

02 Sep 2026

hayfever-1280x720

Fluticasone 0.05pc nasal spray reclassified to be available for children aged 12 and over

MHRA reclassifies fluticasone nasal spray as a P medicine for those aged 12 years and over, available from February 2026.

16 Dec 2025

main pic spread copy.jpg

Key clinical developments in 2021

This module provides an update of the major developments in pharmacy practice during 2021.

16 Dec 2021

Change privacy settings